Transcervical carotid artery stenting compared to transfemoral carotid artery stenting and carotid endarterectomy: perioperative and short-term results from a single center - Report - MDSpire
Advertisement
Transcervical carotid artery stenting compared to transfemoral carotid artery stenting and carotid endarterectomy: perioperative and short-term results from a single center
Clinical Report: Comparison of Perioperative and Short-Term Outcomes in Carotid Revascularization
Overview
This study compares the perioperative and six-month outcomes of Transcervical Carotid Artery Stenting (TC-CAS), Transfemoral Carotid Artery Stenting (TF-CAS), and Carotid Endarterectomy (CEA) in patients with carotid artery stenosis. Results indicate comparable perioperative stroke rates across all techniques, with TC-CAS showing no stroke or TIA events at six months.
Background
Carotid artery stenosis is a significant contributor to ischemic stroke, necessitating effective revascularization strategies. CEA has long been the standard treatment; however, minimally invasive alternatives like CAS are increasingly utilized, especially in high-risk patients. Understanding the comparative outcomes of these techniques is crucial for optimizing patient care and reducing stroke risk.
Data Highlights
Procedure
Perioperative Stroke Rate
Six-Month Restenosis Rate
Hospital Costs (CNY)
TF-CAS
2.5%
3.7%
57.6 ± 22.8 × 103
TC-CAS
2.0%
2.0%
56.4 ± 20.1 × 103
CEA
1.1%
4.5%
25.0 ± 9.8 × 103
Key Findings
Perioperative stroke rates were low and comparable: TF-CAS 2.5%, TC-CAS 2.0%, CEA 1.1% (P = 0.802).
Cranial nerve injury was observed exclusively in the CEA group.
Six-month restenosis rates showed no significant difference: TF-CAS 3.7%, TC-CAS 2.0%, CEA 4.5% (P = 0.752).
No stroke or TIA events were recorded in the TC-CAS group during the six-month follow-up.
Hospital costs were significantly lower for CEA compared to TF-CAS and TC-CAS (P < 0.001).
TC-CAS is a promising alternative for patients with high-risk anatomy.
Clinical Implications
The findings suggest that TC-CAS is a safe and effective option for carotid revascularization, particularly in patients with challenging anatomical features. Clinicians should consider TC-CAS as a viable alternative to TF-CAS and CEA, especially for high-risk patients, while also being mindful of the lower costs associated with CEA.
Conclusion
TC-CAS demonstrates favorable perioperative safety and short-term outcomes compared to TF-CAS and CEA. Further long-term studies are needed to validate these findings and assess the sustained efficacy of TC-CAS.
For years, chronic stroke patients heard familiar feedback regarding their ability to regain strength and mobility after ischemic strokes caused upper-extremity deficits.
Researchers examined how variation in time to hip fracture surgery relates to mortality, complications, length of stay, and functional recovery in older adults.